Literature DB >> 21502812

Antagonistic crosstalk between APC and HIF-1α.

Inke Näthke1, Sonia Rocha.   

Abstract

Most colorectal cancers have mutations in the tumor suppressor APC. The best-understood function of APC is its participation in a protein complex that regulates the availability of β-catenin. Solid tumors are characterized by the presence of hypoxia as well as inflammation, which leads to the upregulation of Hypoxia Inducible Factors like HIF-1α. We recently demonstrated a novel antagonistic link between APC and HIF-1α. We found that hypoxia results in reduced levels of APC mRNA and protein via a direct HIF-1α-dependent mechanism. Similarly, APC mediates the repression of HIF-1α. However, this requires wild-type APC, low levels of β-catenin and NFκB activity. These results reveal the downregulation of APC as a novel mechanism that contributes to the survival advantage induced by hypoxia and cytokines such as TNFα. Our data indicate that loss-of-function mutations in APC result in the engagement of the hypoxia response. Importantly, this suggests that other stimuli that induce HIF, such as inflammatory cytokines and oncogenes, alter APC function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21502812      PMCID: PMC3127156          DOI: 10.4161/cc.10.10.15638

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  25 in total

Review 1.  Linking colorectal cancer to Wnt signaling.

Authors:  M Bienz; H Clevers
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 2.  Hydroxylation of hypoxia-inducible transcription factors and chemical compounds targeting the HIF-alpha hydroxylases.

Authors:  K Bruegge; W Jelkmann; E Metzen
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

Review 3.  Cell regulation by the Apc protein Apc as master regulator of epithelia.

Authors:  Brooke M McCartney; Inke S Näthke
Journal:  Curr Opin Cell Biol       Date:  2008-03-24       Impact factor: 8.382

Review 4.  Good cop, bad cop: the different faces of NF-kappaB.

Authors:  N D Perkins; T D Gilmore
Journal:  Cell Death Differ       Date:  2006-05       Impact factor: 15.828

Review 5.  The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease.

Authors:  K J O'Byrne; A G Dalgleish; M J Browning; W P Steward; A L Harris
Journal:  Eur J Cancer       Date:  2000-01       Impact factor: 9.162

Review 6.  Regulating cellular oxygen sensing by hydroxylation.

Authors:  Joachim Fandrey; Thomas A Gorr; Max Gassmann
Journal:  Cardiovasc Res       Date:  2006-05-10       Impact factor: 10.787

7.  Mutated APC and Asef are involved in the migration of colorectal tumour cells.

Authors:  Yoshihiro Kawasaki; Rina Sato; Tetsu Akiyama
Journal:  Nat Cell Biol       Date:  2003-03       Impact factor: 28.824

8.  A two-step model for colon adenoma initiation and progression caused by APC loss.

Authors:  Reid A Phelps; Stephanie Chidester; Somaye Dehghanizadeh; Jason Phelps; Imelda T Sandoval; Kunal Rai; Talmage Broadbent; Sharmistha Sarkar; Randall W Burt; David A Jones
Journal:  Cell       Date:  2009-05-15       Impact factor: 41.582

9.  Evolutionary conserved regulation of HIF-1β by NF-κB.

Authors:  Patrick van Uden; Niall S Kenneth; Ryan Webster; H Arno Müller; Sharon Mudie; Sonia Rocha
Journal:  PLoS Genet       Date:  2011-01-27       Impact factor: 5.917

10.  Regulation of hypoxia-inducible factor-1alpha by NF-kappaB.

Authors:  Patrick van Uden; Niall S Kenneth; Sonia Rocha
Journal:  Biochem J       Date:  2008-06-15       Impact factor: 3.766

View more
  6 in total

1.  HAF drives the switch of HIF-1α to HIF-2α by activating the NF-κB pathway, leading to malignant behavior of T24 bladder cancer cells.

Authors:  Zhenfeng Guan; Chen Ding; Yiqing Du; Kai Zhang; Jian Ning Zhu; Tingting Zhang; Dalin He; Shan Xu; Xinyang Wang; Jinhai Fan
Journal:  Int J Oncol       Date:  2013-12-06       Impact factor: 5.650

Review 2.  The role of hypoxia in inflammatory disease (review).

Authors:  John Biddlestone; Daniel Bandarra; Sonia Rocha
Journal:  Int J Mol Med       Date:  2015-01-27       Impact factor: 4.101

Review 3.  Hypoxia and Inflammation in Cancer, Focus on HIF and NF-κB.

Authors:  Laura D'Ignazio; Michael Batie; Sonia Rocha
Journal:  Biomedicines       Date:  2017-05-09

Review 4.  Targeting Wnt/β-Catenin Pathways in Primary Liver Tumours: From Microenvironment Signaling to Therapeutic Agents.

Authors:  Federico Selvaggi; Teresa Catalano; Roberto Cotellese; Gitana Maria Aceto
Journal:  Cancers (Basel)       Date:  2022-04-10       Impact factor: 6.575

5.  Transmembrane Protein 100 Inhibits the Progression of Colorectal Cancer by Promoting the Ubiquitin/Proteasome Degradation of HIF-1α.

Authors:  Ying Zheng; Yitong Zhao; Jiong Jiang; Baicang Zou; Lei Dong
Journal:  Front Oncol       Date:  2022-07-19       Impact factor: 5.738

6.  Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer Via Downregulation of Nuclear p65 and HIF-1α.

Authors:  Alaa A A Aljabali; Hamid A Bakshi; Faruk L Hakkim; Yusuf A Haggag; Khalid M Al-Batanyeh; Mazhar S Al Zoubi; Bahaa Al-Trad; Mohamed M Nasef; Saurabh Satija; Meenu Mehta; Kavita Pabreja; Vijay Mishra; Mohammed Khan; Salem Abobaker; Ibrahim M Azzouz; Harish Dureja; Ritesh M Pabari; Ashref Ali K Dardouri; Prashant Kesharwani; Gaurav Gupta; Shakti Dhar Shukla; Parteek Prasher; Nitin B Charbe; Poonam Negi; Deepak N Kapoor; Dinesh Kumar Chellappan; Mateus Webba da Silva; Paul Thompson; Kamal Dua; Paul McCarron; Murtaza M Tambuwala
Journal:  Cancers (Basel)       Date:  2020-01-01       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.